An Open Trial of Sertraline for Cocaine Abuse

References

• Kosten T A, Kosten T R. Pharmacological blocking agents for treating substance abuse. J New Ment Dis 1991; 179: 583–592
   PubMed Web of Science ®Google Scholar
• Wise R A. Catecholamine theories of reward: a critical review. Brain Res 1978; 152: 215–247
   PubMed Web of Science ®Google Scholar
• Montgomery A M, Rose I C, Herberg L J. 5–HT 1A agonisu and dopamine: the effects of 8–OH‐DPAT and buspuone on brain stimulation reward. J Neural Transm 1991; 83: 139–148
   Web of Science ®Google Scholar
• Cunningham K A, Lakokskim. Electrophysiological effects of cocaine and procaine on dorsal raphe serotonin neurons. Eur J Pharmacol 1988; 148: 457–462
   PubMed Web of Science ®Google Scholar
• Galloway Mp. Regulation of dopamine and serotonin synthesis by acute administration of cocaine. Synapse 1990; 6: 63–72
   PubMed Web of Science ®Google Scholar
• Naranjo C A, Kadlec K E, Sanhueza P, et al. Fluoxet‐ine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther 1990; 47: 490–498
   PubMed Web of Science ®Google Scholar
• Shopsin B. Second generation antidepressants: a clinical pharmacotherapeutic research strategy. Psychophamacol Bull 1981; 17: 33–35
   PubMedGoogle Scholar
• Gawin F H, Kleber H D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 1986; 43: 107–113
   PubMed Web of Science ®Google Scholar
• Rounsaville B J, Anton S F, Carroll K, et al. Psychiatric diagnosis of treatment seeking cocaine abusers. Arch Gen Psychtry 1991; 48: 43–51
   PubMed Web of Science ®Google Scholar
• Asberg M, Errikson B. The effects of serotonin re‐uptake blockers on depression. J Clin Psychiauy 1986; 41: 23–35
   Google Scholar
• Batki S L, Manfredi L B, Sorensen J L, et al (1990) Fluoxetine for cocaine abuse in methadone patients: preliminary findings, in Problems of Drug Dependence, 1990. Proceedings of the 52nd Annual Scientific Meeting, NIDA Res Monogr 105. 1990. National Institute on Drug Abuse, Rockville, MD, 516–517
   Google Scholar
• Koe B K, Weissman A, Welch W M, et al. Sertraline, 1S,4S‐N‐methy1–4–(3,4–dichlorophenyl)‐1,2,3,4–tetrahydro‐1–naphthyhmine, a new uptake inhibitor with selectivity for serotonin. J Pharmacol Exp Ther 1983; 226: 686–700
   PubMed Web of Science ®Google Scholar
• Doogan D P, Caillard V. Sertraline: a new antide‐pressant. J Clin Psychiatry 1988; 49(suppl 8)46–51
   PubMedGoogle Scholar
• Spitzer R L, Endicott J. Schedule for Affective Disorders and Schizophrenia. Biometrics Research Department, New York State Psychiatric Institute, New York 1975
   Google Scholar
• Spitzer R L, Endicott J, Robins E. The Research Diagnostic Criteria. Biometria Research Department, New York State Psychiatric Institute, New York 1975
   Google Scholar
• McLellan A T, Luborsky L, Woody G E, et al. An improved diagnostic evaluation instrument for substance abuse patients. J Nerv Ment Dis 1980; 1698: 26–33
   Web of Science ®Google Scholar
• Beck A T, Beck R W. Screening depressed patients in family practice: a rapid technic. Postgad Med 1972; 52: 1181–1185
   Web of Science ®Google Scholar
• Endicott J, Spitzer R L, Fleiss J L, et al. The Global Assessment Scale. Arch Gen Psychiatry 1976; 33: 766–771
   PubMed Web of Science ®Google Scholar
• Gawin F H, Kleber H D, Byck R, et al. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989; 46: 117–121
   PubMed Web of Science ®Google Scholar
• Cronson A J, Flemenbaum A. Antagonism of cocaine highs by lithium. Am J Psychiauy 1978; 135: 856–857
   PubMed Web of Science ®Google Scholar
• Nunes E V, McGrath P J, Wager S, et al. Lithium treatment for cocaine abusers with bipolar spectrum disorders. Am J Psychiatry 1990; 147: 655–657
   PubMed Web of Science ®Google Scholar
• Weddington W W, Brown B S, Haemen C A, et al. Changes in mood, craving, and sleep during short‐term abstinence reported by male cocaine addicts: a controlled, residential study. Arch Gen Psychiatry 1990; 47: 861–868
   PubMed Web of Science ®Google Scholar
• Ziedonis D, Kosten T R. Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol Bull 1991; 27: 337–343
   PubMed Web of Science ®Google Scholar